Wirdatun Nafisah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Wirdatun Nafisah has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Elma Sakinatus Sajidah
Kanazawa University
2 shared publications - Fachrur Rizal Mahendra
Department of Biochemistry, Faculty of Mathematics and Natural Sciences, Bogor agricultural University
2 shared publications - Fatima Shahid
National University of Malaysia
2 shared publications - Gusnia Meilin Gholam
Department of Biochemistry, Faculty of Mathematics and Natural Sciences, IPB University, Dramaga Campus, Bogor, 16680, Indonesia
2 shared publications - Maheswari Alfira Dwicesaria
IPB University
2 shared publications - Abu Hanifah Ramadhani
Biology Department, Faculty of Mathematics and Natural Sciences, Brawijaya University, Jl. Veteran Malang 65145, East Java, Indonesia
1 shared publication
Latest Publications
- Open Access
- 30 September 2026
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 3 (19) , 2563-2575
Cytotoxic and Apoptosis-Associated Activity of Schefflera elliptica (Blume) Harms Ethanolic Extract in T47D Breast Cancer Cells Supported by LC-HRMS Profiling and Molecular Docking
Breast cancer continues to impose a substantial global health burden, and natural products remain an important source of candidates for anticancer research. This study investigated the cytotoxic and apoptosis-associated effects of the ethanolic extract of Schefflera elliptica against T47D human breast cancer cells. Cytotoxicity was evaluated using the MTT assay, while apoptosis-associated responses were assessed by Annexin V-FITC/propidium iodide flow cytometry and caspase-3 and caspase-8 immunofluorescence. Metabolite profiling was performed using liquid chromatography–high-resolution mass spectrometry (LC-HRMS), followed by exploratory molecular docking of selected metabolites against the anti-apoptotic protein Bcl-2. The crude ethanolic extract exhibited moderate cytotoxic activity, with an IC50 of 339 μg/mL. Treatment increased the Annexin V-positive cell population, with significant increases observed at 160 and 320 μg/mL, and was accompanied by increased caspase-3 and caspase-8 immunofluorescence signals. LC-HRMS profiling yielded 39 putatively annotated metabolites, with choline, L-norleucine, and valine among the most abundant. Molecular docking predicted interactions of these metabolites within the Bcl-2 binding pocket, although their predicted binding affinities were weaker than those of venetoclax. Overall, the findings indicate that S. elliptica ethanolic extract exhibits moderate cytotoxic activity accompanied by apoptosis-associated cellular responses in T47D cells. The integrated biological, metabolomic, and computational findings provide a basis for further bioactivity-guided investigation of the active constituents and their underlying mechanisms.
- 30 September 2026
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 3 (19) , 2563-2575
Open AccessCytotoxic and Apoptosis-Associated Activity of Schefflera elliptica (Blume) Harms Ethanolic Extract in T47D Breast Cancer Cells Supported by LC-HRMS Profiling and Molecular Docking
Breast cancer continues to impose a substantial global health burden, and natural products remain an important source of candidates for anticancer research. This study investigated the cytotoxic and apoptosis-associated effects of the ethanolic extract of Schefflera elliptica against T47D human breast cancer cells. Cytotoxicity was evaluated using the MTT assay, while apoptosis-associated responses were assessed by Annexin V-FITC/propidium iodide flow cytometry and caspase-3 and caspase-8 immunofluorescence. Metabolite profiling was performed using liquid chromatography–high-resolution mass spectrometry (LC-HRMS), followed by exploratory molecular docking of selected metabolites against the anti-apoptotic protein Bcl-2. The crude ethanolic extract exhibited moderate cytotoxic activity, with an IC50 of 339 μg/mL. Treatment increased the Annexin V-positive cell population, with significant increases observed at 160 and 320 μg/mL, and was accompanied by increased caspase-3 and caspase-8 immunofluorescence signals. LC-HRMS profiling yielded 39 putatively annotated metabolites, with choline, L-norleucine, and valine among the most abundant. Molecular docking predicted interactions of these metabolites within the Bcl-2 binding pocket, although their predicted binding affinities were weaker than those of venetoclax. Overall, the findings indicate that S. elliptica ethanolic extract exhibits moderate cytotoxic activity accompanied by apoptosis-associated cellular responses in T47D cells. The integrated biological, metabolomic, and computational findings provide a basis for further bioactivity-guided investigation of the active constituents and their underlying mechanisms.
- Open Access
- 23 July 2026
- Published by Taylor & Francis in Cogent Education
- Vol. 13 (1)
Integrating biotechnology and bioinformatics in education: development of an anti-cancer e-module based on in-silico research
1. Education worldwide continues to develop alongside advancements in technology and information (Amhag et al., 2019). A crucial factor in this progress is the adaptability of students to the deman...
- 23 July 2026
- Published by Taylor & Francis in Cogent Education
- Vol. 13 (1)
Open AccessIntegrating biotechnology and bioinformatics in education: development of an anti-cancer e-module based on in-silico research
1. Education worldwide continues to develop alongside advancements in technology and information (Amhag et al., 2019). A crucial factor in this progress is the adaptability of students to the deman...
- Open Access
- 15 February 2026
- Published by AMG Transcend Association in Biointerface Research in Applied Chemistry
- Vol. 16 (1)
Computational Exploration of Bcl-2 Inhibitors from Codiaeum variegatum: Docking, MD, and DFT Analyses
Cancer remains a major health issue, and Bcl-2 inhibits apoptosis. This study explored the phytochemicals of Codiaeum variegatum as potential Bcl-2 inhibitors. Receptor–ligand docking was conducted with YASARA, followed by 300 ns MD using AMBER14. ADME and DFT analyses were used to characterize the pharmacokinetics and electronic properties of the inhibitor candidates. The large-scale data generated from the 300-nanosecond MD simulations were further processed to map the energy landscapes using PCA and DCCM analysis in R Studio. We successfully applied the QM-AM1 method to the preparation and execution of molecular docking studies. Among the 17 phytochemical compounds isolated from C. variegatum, taraxerol demonstrated the most promising binding energy, with a docking score of −8.868 kcal/mol, which is comparable to that of the co-crystallized reference ligand, venetoclax. Taraxerol also satisfied the ADME criteria based on Lipinski’s Rule of Five, with only a single rule violation, and DFT calculations confirmed its stability, exhibiting an energy gap of −0.1805 eV. Furthermore, a 300 ns MD simulation revealed that the binding energy of taraxerol, computed using the MM-PBSA method, was more favorable than that of venetoclax, with taraxerol yielding 303.235 kJ/mol in complex with Bcl-2, compared to 291.115 kJ/mol for venetoclax. PCA and DCCM analyses additionally supported the dynamic stability of taraxerol as a potential Bcl-2 inhibitor. Although ADME predictions suggest a favorable safety profile, further in vitro and in vivo validation is required to substantiate its therapeutic potential.
- 15 February 2026
- Published by AMG Transcend Association in Biointerface Research in Applied Chemistry
- Vol. 16 (1)
Open AccessComputational Exploration of Bcl-2 Inhibitors from Codiaeum variegatum: Docking, MD, and DFT Analyses
Cancer remains a major health issue, and Bcl-2 inhibits apoptosis. This study explored the phytochemicals of Codiaeum variegatum as potential Bcl-2 inhibitors. Receptor–ligand docking was conducted with YASARA, followed by 300 ns MD using AMBER14. ADME and DFT analyses were used to characterize the pharmacokinetics and electronic properties of the inhibitor candidates. The large-scale data generated from the 300-nanosecond MD simulations were further processed to map the energy landscapes using PCA and DCCM analysis in R Studio. We successfully applied the QM-AM1 method to the preparation and execution of molecular docking studies. Among the 17 phytochemical compounds isolated from C. variegatum, taraxerol demonstrated the most promising binding energy, with a docking score of −8.868 kcal/mol, which is comparable to that of the co-crystallized reference ligand, venetoclax. Taraxerol also satisfied the ADME criteria based on Lipinski’s Rule of Five, with only a single rule violation, and DFT calculations confirmed its stability, exhibiting an energy gap of −0.1805 eV. Furthermore, a 300 ns MD simulation revealed that the binding energy of taraxerol, computed using the MM-PBSA method, was more favorable than that of venetoclax, with taraxerol yielding 303.235 kJ/mol in complex with Bcl-2, compared to 291.115 kJ/mol for venetoclax. PCA and DCCM analyses additionally supported the dynamic stability of taraxerol as a potential Bcl-2 inhibitor. Although ADME predictions suggest a favorable safety profile, further in vitro and in vivo validation is required to substantiate its therapeutic potential.
- Open Access
- 15 February 2026
- Published by AMG Transcend Association in Biointerface Research in Applied Chemistry
- Vol. 16 (1)
Computational Evaluation of Sea Buckthorn Phytochemicals as CDPK3 and CDPK4 Inhibitors against Plasmodium falciparum
Malaria remains a primary global health concern, and targeting proteins from the calcium-dependent protein kinase (CDPK) family of Plasmodium falciparum represents a novel and promising therapeutic strategy. In this study, we investigated the molecular interactions between sea buckthorn-derived compounds and P. falciparum CDPK3 and CDPK4 to address the unexplored antimalarial potential of this traditionally used medicinal plant. The active sites of each CDPK protein were predicted to facilitate docking analysis. In silico assessments of absorption, distribution, metabolism, and excretion (ADME), along with PASS, were used to evaluate drug-likeness properties and antiprotozoal potential. Density functional theory (DFT) calculations were performed to predict the electronic reactivity of potential inhibitors, and molecular dynamics (MD) simulations were used to evaluate complex stability. The results showed that the active sites of CDPK3 and CDPK4 were successfully identified, with 39 amino acid residues for CDPK3 and 105 for CDPK4. Molecular docking analyses demonstrated favorable binding affinities, ranging from 4.026 to 8.917 kcal/mol for the CDPK3–ligand complexes and from 5.072 to 11.09 kcal/mol for the CDPK4–ligand complexes. Among all evaluated compounds, oleanolic acid and ursolic acid exhibited the highest predicted drug-likeness and strong antiprotozoal activity, as supported by PASS predictions. DFT calculations further reinforced their inhibitory potential, with both compounds showing an extremely small energy gap difference of −0.0002 eV. In addition, MD simulations using normal mode analysis (NMA) showed that the candidate inhibitors formed stable complexes with both CDPK3 and CDPK4.
- 15 February 2026
- Published by AMG Transcend Association in Biointerface Research in Applied Chemistry
- Vol. 16 (1)
Open AccessComputational Evaluation of Sea Buckthorn Phytochemicals as CDPK3 and CDPK4 Inhibitors against Plasmodium falciparum
Malaria remains a primary global health concern, and targeting proteins from the calcium-dependent protein kinase (CDPK) family of Plasmodium falciparum represents a novel and promising therapeutic strategy. In this study, we investigated the molecular interactions between sea buckthorn-derived compounds and P. falciparum CDPK3 and CDPK4 to address the unexplored antimalarial potential of this traditionally used medicinal plant. The active sites of each CDPK protein were predicted to facilitate docking analysis. In silico assessments of absorption, distribution, metabolism, and excretion (ADME), along with PASS, were used to evaluate drug-likeness properties and antiprotozoal potential. Density functional theory (DFT) calculations were performed to predict the electronic reactivity of potential inhibitors, and molecular dynamics (MD) simulations were used to evaluate complex stability. The results showed that the active sites of CDPK3 and CDPK4 were successfully identified, with 39 amino acid residues for CDPK3 and 105 for CDPK4. Molecular docking analyses demonstrated favorable binding affinities, ranging from 4.026 to 8.917 kcal/mol for the CDPK3–ligand complexes and from 5.072 to 11.09 kcal/mol for the CDPK4–ligand complexes. Among all evaluated compounds, oleanolic acid and ursolic acid exhibited the highest predicted drug-likeness and strong antiprotozoal activity, as supported by PASS predictions. DFT calculations further reinforced their inhibitory potential, with both compounds showing an extremely small energy gap difference of −0.0002 eV. In addition, MD simulations using normal mode analysis (NMA) showed that the candidate inhibitors formed stable complexes with both CDPK3 and CDPK4.
- 1 January 2026
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 14 (1) , 2399
Elucidation of therapeutic targets and mechanisms of Clitoria ternatea L. in colorectal cancer inhibition using network pharmacology and bioinformatics approaches
Context: Colorectal cancer (CRC) remains one of the leading causes of cancer-related mortality worldwide, highlighting the need for novel targeted therapies. Clitoria ternatea (CT), a medicinal plant with diverse bioactive compounds, shows promising anticancer potential in preclinical studies, yet its molecular mechanisms in CRC remain poorly understood. Aims: To elucidate the anti-CRC mechanisms and potential therapeutic targets of CT compounds through integrated bioinformatics and network pharmacology approaches. Methods: Active CT compounds were obtained from the literature and screened for drug-likeness. CRC-associated targets from GeneCards were intersected with CT-related targets to identify overlapping candidates. Overlapping targets were analyzed using network pharmacology, Gene Ontology (GO), and KEGG pathway enrichment. Hub genes were validated through mRNA expression, pathological stage correlations, and molecular docking, followed by 100-ns molecular dynamics simulations to assess binding stability. Results: Thirty-two CT compounds and eleven potential CRC-related targets were identified, with CCND1 and HSP90AB1 emerging as central hub genes linked to the PI3K/AKT and CRC signaling pathways. Ellagic acid exhibited the strongest binding affinity to CCND1 (−8.3 kcal/mol) and HSP90AB1 (−9.5 kcal/mol), and maintained conformational stability during simulations, outperforming control ligands. These findings highlight the multi-target therapeutic potential of CT in CRC. Further in vitro studies are needed to investigate CCND1 and HSP90AB1 expression, cell proliferation, and apoptosis in CRC models. Conclusions: CT exhibits multi-target anti-CRC potential by modulating CCND1 and HSP90AB1, suggesting a mechanistic link to the PI3K/AKT signaling pathway. These results support further validation (in vitro and in vivo studies) of CT and ellagic acid as potential adjuvant CRC therapies.
- 1 January 2026
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 14 (1) , 2399
Elucidation of therapeutic targets and mechanisms of Clitoria ternatea L. in colorectal cancer inhibition using network pharmacology and bioinformatics approaches
Context: Colorectal cancer (CRC) remains one of the leading causes of cancer-related mortality worldwide, highlighting the need for novel targeted therapies. Clitoria ternatea (CT), a medicinal plant with diverse bioactive compounds, shows promising anticancer potential in preclinical studies, yet its molecular mechanisms in CRC remain poorly understood. Aims: To elucidate the anti-CRC mechanisms and potential therapeutic targets of CT compounds through integrated bioinformatics and network pharmacology approaches. Methods: Active CT compounds were obtained from the literature and screened for drug-likeness. CRC-associated targets from GeneCards were intersected with CT-related targets to identify overlapping candidates. Overlapping targets were analyzed using network pharmacology, Gene Ontology (GO), and KEGG pathway enrichment. Hub genes were validated through mRNA expression, pathological stage correlations, and molecular docking, followed by 100-ns molecular dynamics simulations to assess binding stability. Results: Thirty-two CT compounds and eleven potential CRC-related targets were identified, with CCND1 and HSP90AB1 emerging as central hub genes linked to the PI3K/AKT and CRC signaling pathways. Ellagic acid exhibited the strongest binding affinity to CCND1 (−8.3 kcal/mol) and HSP90AB1 (−9.5 kcal/mol), and maintained conformational stability during simulations, outperforming control ligands. These findings highlight the multi-target therapeutic potential of CT in CRC. Further in vitro studies are needed to investigate CCND1 and HSP90AB1 expression, cell proliferation, and apoptosis in CRC models. Conclusions: CT exhibits multi-target anti-CRC potential by modulating CCND1 and HSP90AB1, suggesting a mechanistic link to the PI3K/AKT signaling pathway. These results support further validation (in vitro and in vivo studies) of CT and ellagic acid as potential adjuvant CRC therapies.
- 1 January 2026
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 14 (1) , 2394
GC-MS profiling and in silico multi-target docking of carvone, p-cymene, and linalool from Cuminum cyminum seeds extract against breast cancer proteins
Context: Breast cancer remains the most prevalent malignancy among women and presents therapeutic challenges due to adverse effects associated with conventional treatments. Cuminum cyminum seeds extract (CCSE), recognized for its antioxidant and antibacterial properties, has been investigated as a potential source of alternative therapeutic agents. Aims: To profile the phytochemical constituents of CCSE using GC-MS and to evaluate the predicted interactions of selected compounds with breast cancer–related proteins through in silico molecular docking analyses. Methods: The ethanolic extract of CCSE was analyzed by GC-MS, yielding the identification of 269 phytoconstituents. From these, three bioactive compounds—carvone, p-cymene, and linalool—were selected for further evaluation. Their potential anticancer activities were predicted using the PASS and CLC-Pred platforms, while drug-likeness properties were assessed through SwissADME. In silico toxicity profiles were also predicted using the ProTox-3.0 webserver. Pathway interactions were analyzed using the STITCH database. Molecular docking studies were then performed with AutoDock Vina in PyRx against Erα, MDM2, HER2, and caspase-3, with doxorubicin used as a reference drug. Results: The selected compounds were predicted to have potential anticancer activity against breast cancer through multiple mechanisms, including regulation of apoptosis. Carvone and p-cymene showed favorable predicted binding affinities for MDM2 and HER2 compared with doxorubicin, suggesting possible tumor-suppressive effects. Linalool was predicted to interact with MDM2, caspase-3, ERα, and HER2, with some affinities comparable to those of doxorubicin, indicating a potential role in modulating apoptosis pathways and receptor-mediated signaling. These findings provide preliminary in silico evidence of the breast cancer–related anticancer potential of CCSE bioactive compounds relative to doxorubicin, and further experimental validation is required. Conclusions: These findings suggest that CCSE-derived compounds may possess potential anticancer activity against breast cancer; however, further in vitro and in vivo validation is necessary.
- 1 January 2026
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 14 (1) , 2394
GC-MS profiling and in silico multi-target docking of carvone, p-cymene, and linalool from Cuminum cyminum seeds extract against breast cancer proteins
Context: Breast cancer remains the most prevalent malignancy among women and presents therapeutic challenges due to adverse effects associated with conventional treatments. Cuminum cyminum seeds extract (CCSE), recognized for its antioxidant and antibacterial properties, has been investigated as a potential source of alternative therapeutic agents. Aims: To profile the phytochemical constituents of CCSE using GC-MS and to evaluate the predicted interactions of selected compounds with breast cancer–related proteins through in silico molecular docking analyses. Methods: The ethanolic extract of CCSE was analyzed by GC-MS, yielding the identification of 269 phytoconstituents. From these, three bioactive compounds—carvone, p-cymene, and linalool—were selected for further evaluation. Their potential anticancer activities were predicted using the PASS and CLC-Pred platforms, while drug-likeness properties were assessed through SwissADME. In silico toxicity profiles were also predicted using the ProTox-3.0 webserver. Pathway interactions were analyzed using the STITCH database. Molecular docking studies were then performed with AutoDock Vina in PyRx against Erα, MDM2, HER2, and caspase-3, with doxorubicin used as a reference drug. Results: The selected compounds were predicted to have potential anticancer activity against breast cancer through multiple mechanisms, including regulation of apoptosis. Carvone and p-cymene showed favorable predicted binding affinities for MDM2 and HER2 compared with doxorubicin, suggesting possible tumor-suppressive effects. Linalool was predicted to interact with MDM2, caspase-3, ERα, and HER2, with some affinities comparable to those of doxorubicin, indicating a potential role in modulating apoptosis pathways and receptor-mediated signaling. These findings provide preliminary in silico evidence of the breast cancer–related anticancer potential of CCSE bioactive compounds relative to doxorubicin, and further experimental validation is required. Conclusions: These findings suggest that CCSE-derived compounds may possess potential anticancer activity against breast cancer; however, further in vitro and in vivo validation is necessary.
- Open Access
- 29 February 2024
- Published by Pensoft Publishers in Pharmacia
- Vol. 71, 1-7
Aqueous black rice (Oryza sativa L. indica) extract enhanced the activation of CD4+ and CD8+ T cells in mouse breast cancer model
Black rice is a functional food of Indonesia that has several pharmaceutical activities including anti-cancer. This study aimed to evaluate the immunomodulatory potential of aqueous black rice (ABR) extract on mouse breast cancer model. A carcinogen, 7,12-dimethylbenz[a]anthracene (DMBA), was applied for breast cancer induction in mice. The study was designed to be seven groups (six mice in each group), including Normal or control group (N), a Cancer (C; DMBA-induced mice) group, Cisplatin (Cis; DMBA-induced mice + Cisplatin) treatment group, and DMBA-induced mice + ABR extract (ABR1; dose 1 or 0.2 g/kg, ABR2; dose 2 or 0.3 g/kg, ABR3; dose 3 or 0.4 g/kg, and ABR4; dose 4 or 0.5 g/kg) treatment group. The cancer-bearing mice were given ABR extract for two weeks, and flow cytometry was used to assess the numbers of CD4 + and CD8 + T cells, as well as the production of inflammatory cytokines IL-17, TNFα, and IFNγ. The histopathology of breast tissue in mice was analyzed using hematoxylin and eosin staining and microscope observation. The induction of DMBA in mice lower the activation of CD4 + and CD8 + T cells, and induced IL-17, TNFα, and IFNγ production. The histology of the mammary tissue of the untreated mice demonstrated an infiltration of cancer cells toward stroma, whereas that of the treated groups, especially those under high doses of ABR extract, showed a better prognosis, exhibiting a reduction in cancer cells surrounded by a relatively larger number of adipose tissues. The activation of CD4 + and CD8 + T cells, as well as the reduction of cytokines (IL-17, TNFα, and IFNγ), were thought to be influenced by ABR extract. The activation of T cells optimized the elimination of cancer cells activity; moreover, the production of pro-tumor cytokines was inhibited.
- 29 February 2024
- Published by Pensoft Publishers in Pharmacia
- Vol. 71, 1-7
Open AccessAqueous black rice (Oryza sativa L. indica) extract enhanced the activation of CD4+ and CD8+ T cells in mouse breast cancer model
Black rice is a functional food of Indonesia that has several pharmaceutical activities including anti-cancer. This study aimed to evaluate the immunomodulatory potential of aqueous black rice (ABR) extract on mouse breast cancer model. A carcinogen, 7,12-dimethylbenz[a]anthracene (DMBA), was applied for breast cancer induction in mice. The study was designed to be seven groups (six mice in each group), including Normal or control group (N), a Cancer (C; DMBA-induced mice) group, Cisplatin (Cis; DMBA-induced mice + Cisplatin) treatment group, and DMBA-induced mice + ABR extract (ABR1; dose 1 or 0.2 g/kg, ABR2; dose 2 or 0.3 g/kg, ABR3; dose 3 or 0.4 g/kg, and ABR4; dose 4 or 0.5 g/kg) treatment group. The cancer-bearing mice were given ABR extract for two weeks, and flow cytometry was used to assess the numbers of CD4 + and CD8 + T cells, as well as the production of inflammatory cytokines IL-17, TNFα, and IFNγ. The histopathology of breast tissue in mice was analyzed using hematoxylin and eosin staining and microscope observation. The induction of DMBA in mice lower the activation of CD4 + and CD8 + T cells, and induced IL-17, TNFα, and IFNγ production. The histology of the mammary tissue of the untreated mice demonstrated an infiltration of cancer cells toward stroma, whereas that of the treated groups, especially those under high doses of ABR extract, showed a better prognosis, exhibiting a reduction in cancer cells surrounded by a relatively larger number of adipose tissues. The activation of CD4 + and CD8 + T cells, as well as the reduction of cytokines (IL-17, TNFα, and IFNγ), were thought to be influenced by ABR extract. The activation of T cells optimized the elimination of cancer cells activity; moreover, the production of pro-tumor cytokines was inhibited.
- Open Access
- 1 July 2023
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 11 (4) , 674-682
Cyperus rotundus L. rhizome extract modulates immune system and induces apoptotic in 4T1-tumor bearing mice
J. Pharm. Pharmacogn. Res., vol. 11, no. 4, pp. 674-682, Jul-Aug 2023. DOI: https://doi.org/10.56499/jppres23.1604_11.4.674 Original Article Cyperus rotundus L. rhizome extract modulates immune system and induces apoptotic in 4T1-tumor bearing mice [Extracto de rizoma de Cyperus rotundus L. modula el sistema inmunitario e induce la apoptosis en ratones portadores de tumores 4T1] Wirdatun Nafisah1,2, Nadia Wahyuningsih3, Cyperus rotundus L. rhizome extract modulates immune system and induces apoptotic in 4T1-tumor bearing mice.
- 1 July 2023
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 11 (4) , 674-682
Open AccessCyperus rotundus L. rhizome extract modulates immune system and induces apoptotic in 4T1-tumor bearing mice
J. Pharm. Pharmacogn. Res., vol. 11, no. 4, pp. 674-682, Jul-Aug 2023. DOI: https://doi.org/10.56499/jppres23.1604_11.4.674 Original Article Cyperus rotundus L. rhizome extract modulates immune system and induces apoptotic in 4T1-tumor bearing mice [Extracto de rizoma de Cyperus rotundus L. modula el sistema inmunitario e induce la apoptosis en ratones portadores de tumores 4T1] Wirdatun Nafisah1,2, Nadia Wahyuningsih3, Cyperus rotundus L. rhizome extract modulates immune system and induces apoptotic in 4T1-tumor bearing mice.
- Open Access
- 5 April 2023
- Published by F1000 Research Ltd in F1000Research
- Vol. 12, 371
Benefit of Asian pigmented rice bioactive compound and its implication in breast cancer: a systematic review
Background: Utilizing the bioactive compounds found in pigmented rice might significantly reduce the risk of breast cancer. This study aims to systematically review existing literature on the benefit of Asian pigmented rice bioactive compounds and their implication in breast cancer. Methods: Searches of the literature were conducted in two databases (Scopus and PubMed) for a systematic review. The keywords resulted in a total of 407 articles, consisting of 103 PubMed and 304 Scopus articles. 32 manuscripts were excluded because the article was over 10 years old. After excluding book chapters and non-English languages, we had 278 potential articles to be reviewed. After checking and screening the title and abstract and eliminating duplicate articles, then 66 articles were obtained. After the selection and elimination of the full-text manuscripts, finally 10 of them which met the inclusion criteria. Result: The included studies in this review were entirely based in Asia. The year of publication ranged from 2013 to 2020. Half of included studies used black rice extract, two used red jasmine rice extracts, and three used Korean rice extracts (black, red, dark purple and brown rice). All studies were conducted in vitro and three studies were compared with in vivo tests on female mice. The pigmented rice is mainly black, red, and dark purple rice, and contains a variety of peonidin-3-glucoside, cyanidin-3-glucoside, γ-oryzanol, γ-tocotrienol, proanthocyanidin, cinnamic acid, and anthocyanins that may act as pro-apoptotic, anti-proliferative, and anti-metastasis of the breast cancer cells. Conclusion: Pigmented rice is a beneficial food which possessed bioactive compounds that may have significant potential concerning a breast cancer.
- 5 April 2023
- Published by F1000 Research Ltd in F1000Research
- Vol. 12, 371
Open AccessBenefit of Asian pigmented rice bioactive compound and its implication in breast cancer: a systematic review
Background: Utilizing the bioactive compounds found in pigmented rice might significantly reduce the risk of breast cancer. This study aims to systematically review existing literature on the benefit of Asian pigmented rice bioactive compounds and their implication in breast cancer. Methods: Searches of the literature were conducted in two databases (Scopus and PubMed) for a systematic review. The keywords resulted in a total of 407 articles, consisting of 103 PubMed and 304 Scopus articles. 32 manuscripts were excluded because the article was over 10 years old. After excluding book chapters and non-English languages, we had 278 potential articles to be reviewed. After checking and screening the title and abstract and eliminating duplicate articles, then 66 articles were obtained. After the selection and elimination of the full-text manuscripts, finally 10 of them which met the inclusion criteria. Result: The included studies in this review were entirely based in Asia. The year of publication ranged from 2013 to 2020. Half of included studies used black rice extract, two used red jasmine rice extracts, and three used Korean rice extracts (black, red, dark purple and brown rice). All studies were conducted in vitro and three studies were compared with in vivo tests on female mice. The pigmented rice is mainly black, red, and dark purple rice, and contains a variety of peonidin-3-glucoside, cyanidin-3-glucoside, γ-oryzanol, γ-tocotrienol, proanthocyanidin, cinnamic acid, and anthocyanins that may act as pro-apoptotic, anti-proliferative, and anti-metastasis of the breast cancer cells. Conclusion: Pigmented rice is a beneficial food which possessed bioactive compounds that may have significant potential concerning a breast cancer.